Hodge, James W <br/><br/>
Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.  [electronic resource] 

 -  Cancer research  Nov 2003 
 - 7942-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>B7-1 Antigen--genetics<br/>CD58 Antigens--genetics<br/>Cancer Vaccines--genetics<br/>Carcinoembryonic Antigen--genetics<br/>Chick Embryo<br/>Female<br/>Intercellular Adhesion Molecule-1--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Transgenes<br/>Vaccines, Synthetic--genetics<br/>Vaccinia virus--genetics